0000919574-14-001928.txt : 20140224 0000919574-14-001928.hdr.sgml : 20140224 20140224101712 ACCESSION NUMBER: 0000919574-14-001928 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140224 DATE AS OF CHANGE: 20140224 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Syneron Medical Ltd. CENTRAL INDEX KEY: 0001291361 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80182 FILM NUMBER: 14635798 BUSINESS ADDRESS: BUSINESS PHONE: 972-4-909-6200 MAIL ADDRESS: STREET 1: INDUSTRIAL ZONE STREET 2: P.O.B. 550 CITY: YOKNEAM ILLIT STATE: L3 ZIP: 20692 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RIMA SENVEST MANAGEMENT, L.L.C. CENTRAL INDEX KEY: 0001328785 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 110 EAST 55TH STREET STREET 2: SUITE 1600 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 514-281-8082 MAIL ADDRESS: STREET 1: 110 EAST 55TH STREET STREET 2: SUITE 1600 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: RIMA MANAGEMENT, LLC DATE OF NAME CHANGE: 20050531 SC 13G/A 1 d1455684_13g-a.htm d1455684_13g-a.htm

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 2)*


Syneron Medical Ltd.
(Name of Issuer)


Ordinary Shares, par value NIS 0.01 per share
(Title of Class of Securities)


M87245102
(CUSIP Number)


February 20, 2014
(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
[_]  Rule 13d-1(b)

[X]  Rule 13d-1(c)

[_]  Rule 13d-1(d)

__________
*      The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 


 
 
 


CUSIP No.
M87245102
    
     
1.
NAME OF REPORTING PERSONS
  
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
  
     
 
RIMA Senvest Management, L.L.C.
  
     
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
 
(a)  [_]
   
(b)  [X]
3.
SEC USE ONLY
  
     
     
     
     
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
  
     
 
Delaware
  
     
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
     
5.
SOLE VOTING POWER
  
     
 
0
  
     
6.
SHARED VOTING POWER
  
     
 
3,734,317
  
     
7.
SOLE DISPOSITIVE POWER
  
     
 
0
  
     
8.
SHARED DISPOSITIVE POWER
  
     
 
3,734,317
  
     
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
  
     
 
3,734,317
  
     
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
     
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
  
     
 
10.32%
  
     
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
  
     
 
OO, IA
  

 
 
 


CUSIP No.
M87245102
 
 
 
 
 
 
 
 
1.
NAME OF REPORTING PERSONS
 
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
 
 
 
 
Senvest Master Fund, L.P.
 
 
 
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
 
 
(a)  [_]
 
 
(b)  [X]
 
 
 
3.
SEC USE ONLY
 
 
 
 
 
 
 
 
 
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
 
 
 
Cayman Islands
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
 
 
 
5.
SOLE VOTING POWER
 
 
 
 
 
0
 
 
 
 
6.
SHARED VOTING POWER
 
 
 
 
 
1,847,726
 
 
 
 
7.
SOLE DISPOSITIVE POWER
 
 
 
 
 
0
 
 
 
 
8.
SHARED DISPOSITIVE POWER
 
 
 
 
 
1,847,726
 
 
 
 
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
1,847,726
 
 
 
 
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
[_]
 
 
 
 
 
 
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
 
 
 
5.12%
 
 
 
 
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
 
 
 
PN
 


 
 
 


CUSIP No.
M87245102
    
     
1.
NAME OF REPORTING PERSONS
  
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
  
     
 
Richard Mashaal
  
     
     
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
 
(a)  [_]
   
(b)  [X]
3.
SEC USE ONLY
  
     
     
     
     
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
  
     
 
Canada
  
     
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
     
5.
SOLE VOTING POWER
  
     
 
0
  
     
6.
SHARED VOTING POWER
  
     
 
3,734,317
  
     
7.
SOLE DISPOSITIVE POWER
  
     
 
0
  
     
8.
SHARED DISPOSITIVE POWER
  
     
 
3,734,317
  
     
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
  
     
 
3,734,317
  
     
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
[_]
     
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
  
     
 
10.32%
  
     
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
  
     
 
IN
  


 
 
 


CUSIP No.
M87245102
    

Item 1.
(a).
Name of Issuer:
  
       
   
Syneron Medical Ltd.
  

 
(b).
Address of issuer's principal executive offices:
  
       
   
Industrial Zone
Yokneam Illit
20692
Tavor Building
P.O.B. 550
Israel
  


Item 2.
(a).
Name of person filing:
  
       
   
Rima Senvest Management, LLC
Senvest Master Fund, L.P.
Richard Mashaal
  

 
(b).
Address or principal business office or, if none, residence:
  
       
   
Rima Senvest Management, LLC
110 East 55th Street Suite 1600
New York, New York  10022
 
Senvest Master Fund, L.P.
c/o State Street (Cayman) Trust, Limited
Gardenia Court, Suite 3307
45 Market Street, Camana Bay
P.O. Box 896
Grand Cayman KY1-1103
Cayman Islands
 
Richard Mashaal
c/o Rima Senvest Management, LLC
110 East 55th Street
Suite 1600
New York, New York  10022
  

 
(c).
Citizenship:
  
       
   
Rima Senvest Management, LLC – Delaware
Senvest Master Fund, L.P. – Cayman Islands
Richard Mashaal – Canada
  

 
(d).
Title of class of securities:
  
       
   
Ordinary Shares, par value NIS 0.01 per share
  

 
(e).
CUSIP No.:
  
       
   
M87245102
  


 
 
 



Item 3.
  
If This Statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a

 
(a)
[_]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

 
(b)
[_]
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 
(c)
[_]
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 
(d)
[_]
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 
(e)
[_]
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

 
(f)
[_]
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

 
(g)
[_]
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 
(h)
[_]
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);

 
(i)
[_]
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 
(j)
[_]
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);

 
(k)
[_]
Group, in accordance with §240.13d-1(b)(1)(ii)(K).  If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:
     


Item 4.
Ownership.

 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 
(a)
Amount beneficially owned:
 
 
  
 
 
Rima Senvest Management, LLC – 3,734,317
Senvest Master Fund, L.P. – 1,847,726
Richard Mashaal – 3,734,317

 
(b)
Percent of class:
 
 
  
 
 
Rima Senvest Management, LLC – 10.32%
Senvest Master Fund, L.P. – 5.12%
Richard Mashaal – 10.32%

 
(c)
Number of shares as to which the person has:

 
Rima Senvest Management, LLC
   
 
 
(i)
Sole power to vote or to direct the vote
0
,
 
 
 
  
 
 
 
(ii)
Shared power to vote or to direct the vote
3,734,317
,
 
 
 
  
 
 
 
(iii)
Sole power to dispose or to direct the disposition of
0
,
 
 
 
  
 
 
 
(iv)
Shared power to dispose or to direct the disposition of
3,734,317
.


 
 
 


 
Senvest Master Fund, L.P.
   
 
 
(i)
Sole power to vote or to direct the vote
0
,
  
 
 
 
  
 
  
 
 
(ii)
Shared power to vote or to direct the vote
1,847,726
,
  
 
 
 
  
 
  
 
 
(iii)
Sole power to dispose or to direct the disposition of
0
,
  
 
 
 
  
 
  
 
 
(iv)
Shared power to dispose or to direct the disposition of
1,847,726
.
  
 
 
 
  
 
  

 
Richard Mashaal
   
 
 
(i)
Sole power to vote or to direct the vote
0
,
  
 
 
 
  
 
  
 
 
(ii)
Shared power to vote or to direct the vote
3,734,317
,
  
 
 
 
  
 
  
 
 
(iii)
Sole power to dispose or to direct the disposition of
0
,
  
 
 
 
  
 
  
 
 
(iv)
Shared power to dispose or to direct the disposition of
3,734,317
.
  
 
 
 
  
 
  

 
Instruction:  For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).
   
 
 
Item 5.
Ownership of Five Percent or Less of a Class.

 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [_].
 
 
Not applicable.


Item 6.
Ownership of More Than Five Percent on Behalf of Another Person.

 
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified.  A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
 
 
Not applicable.


Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 
If a parent holding company or control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary.  If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
 
 
Not applicable.


 
 
 


Item 8.
Identification and Classification of Members of the Group.

 
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group.  If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group.
 
 
Not applicable.
   


Item 9.
Notice of Dissolution of Group.

 
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity.  See Item 5.
 
 
Not applicable.


Item 10.
Certification.


 
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.




 
 
 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 

 
February 24, 2014
 
(Date)

 
RIMA SENVEST MANAGEMENT, LLC*
   
   
 
By:
/s/ George Malikotsis
  
   
Name:           George Malikotsis
   
Title:           Vice President
   
 
SENVEST MASTER FUND, L.P.
   
 
By: RIMA Senvest Management, L.L.C., its general partner
   
 
By:     /s/ George Malikotsis
 
           Name:                                George Malikotsis
 
           Title:                      Vice President
   
 
RICHARD MASHAAL*
   
   
 
By:
/s/ Richard Mashaal
  
   
Name:           Richard Mashaal
     


*           The Reporting Person disclaims beneficial ownership in the shares reported herein except to the extent of their pecuniary interest therein.

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative.  If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference.  The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Note.  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.
 
Attention.  Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).
 

 
 
 


 
Exhibit A


AGREEMENT


Each of the undersigned hereby consents and agrees to this joint filing of the Amendment No. 2 to Schedule 13G for the Ordinary Shares, par value NIS 0.01 per share of Syneron Medical Ltd.
 

 
Dated:  February 24, 2014
RIMA SENVEST MANAGEMENT, LLC
   
   
 
By:
/s/ George Malikotsis
  
   
Name:           George Malikotsis
   
Title:           Vice President
   
 
SENVEST MASTER FUND, L.P.
   
 
By: RIMA Senvest Management, L.L.C., its general partner
   
 
By:     /s/ George Malikotsis
 
           Name:                                George Malikotsis
 
           Title:                      Vice President
   
 
RICHARD MASHAAL
   
   
 
By:
/s/ Richard Mashaal
  
   
Name:           Richard Mashaal
     

 

 


 
SK 01780 0004 1455684